Unknown

Dataset Information

Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis.


ABSTRACT:

Objectives

To investigate the population pharmacokinetics of posaconazole gastroresistant tablets in children with cystic fibrosis (CF) and perform simulations to recommend optimal doses.

Patients and methods

Children from a paediatric CF centre who had received posaconazole tablets and underwent therapeutic drug monitoring were identified from pharmacy records. Relevant clinical data were collated from case notes and electronic patient records and used to develop an allometrically scaled population pharmacokinetic model. A stepwise covariate model-building exercise evaluated the influence of interacting medicines and liver function.

Results

One hundred posaconazole serum concentrations were collected from 37 children with a median age of 14 years (range 7-17). Posaco

SUBMITTER: Bentley S 

PROVIDER: S-EPMC8598294 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature